| Literature DB >> 31492132 |
Nasrin Taherkhani1, Mohammad Mehdi Sepehri2, Shadi Shafaghi3, Toktam Khatibi4.
Abstract
BACKGROUND: Kidney allocation is a multi-criteria and complex decision-making problem, which should also consider ethical issues in addition to the medical aspects. Leading countries in this field use a point scoring system to allocate kidneys. Hence, the purpose of this study is to identify and weight the kidney allocation criteria considering the balance between utility and equity.Entities:
Keywords: Fuzzy Delphi method; Intuitionistic fuzzy AHP; Kidney allocation; Kidney allocation criteria
Mesh:
Year: 2019 PMID: 31492132 PMCID: PMC6729045 DOI: 10.1186/s12911-019-0892-y
Source DB: PubMed Journal: BMC Med Inform Decis Mak ISSN: 1472-6947 Impact factor: 2.796
Fig. 1Proposed framework for identifying and weighting the essential criteria of kidney allocation
shows how to define linguistic scales in triangular fuzzy numbers [42]
| Linguistic Scales | Fuzzy number |
|---|---|
| Very low | (0, 0, 0.1) |
| Low | (0, 0.1, 0.3) |
| Medium low | (0.1, 0.3, 0.5) |
| Medium | (0.3, 0.5, 0.7) |
| Medium high | (0.5, 0.7, 0.9) |
| High | (0.7, 0.9, 1.0) |
| Very high | (0.9, 1.0, 1.0) |
Fig. 2Membership functions of TFN
Fig. 3The AHP framework at all levels
Scale for pairwise comparisons
| Importance level | Corresponding intuitionistic fuzzy sets | Reciprocal intuitionistic fuzzy sets |
|---|---|---|
| Equal Importance (EI) | (1, 1, 1; 1, 1, 1) | ( |
| Weak Importance (WI) | (2, 3, 4; 1, 3, 5) |
|
| Fairly Strong Importance (FSI) | (4, 5, 6; 3, 5, 7) |
|
| Very Strong Importance (VSI) | (6, 7, 8; 5, 7, 9) |
|
| Absolute Importance (AI) | (8, 9, 9; 7, 9, 9) |
|
FDM results on selection/rejection of kidney allocation factors
| Factors | Fuzzy weights | Defuzzy weights | Selected/ Rejected |
|---|---|---|---|
| Blood type compatibility | (0.3,0.6642671, 1) | 0.654756 | Selected |
| HLA matching | (0.3, 0.784858, 1) | 0.694953 | Selected |
| PRA | (0.5, 0.904495, 1) | 0.801498 | Selected |
| Age difference | (0.5, 0.814531, 1) | 0.77151 | Selected |
| Recipient Age | (0.5, 0.844001, 1) | 0.781334 | Selected |
| Location | (0, 0.252012, 0.9) | 0.384004 | Rejected |
| Transplant status | (0, 0.405595, 0.9) | 0.435198 | Rejected |
| Waiting time | (0.3, 0.903077, 1) | 0.734359 | Selected |
| Medical urgency | (0.3, 0.898851, 1) | 0.73295 | Selected |
| Predicted survival | (0.3, 0.779734, 1) | 0.693245 | Selected |
| A prior living donor | (0, 0.424355, 1) | 0.474785 | Rejected |
| THRESHOLD | (0.27272, 0.69779, 0.98181) | 0.650781 |
Pair-wise comparison of criteria
| Equity | Utility | |
|---|---|---|
| Equity | (1,1,1; 1,1,1) | (0.42, 0.50,0.62; 0.37, 0.49, 0.90) |
| Utility | (1.62, 2.03,2.39; 1.12, 2.03, 2.72) | (1,1,1; 1,1,1) |
Pair-wise comparison of sub-criteria for equity
| Medical Urgency | PRA | Recipient Age | Waiting Time | |
|---|---|---|---|---|
| M-U | (1,1,1; 1,1,1) | (3.78,4.36,4.82;3.16,4.36,5.24) | (2.3,2.52,2.66;2.05,2.52,2.78) | (6.21,7.24,7.92;5.16,7.24,8.56) |
| PRA | (0.21,0.23,0.26;0.19,0.23,0.32) | (1,1,1; 1,1,1) | (0.46,0.49,053;0.44,0.49,0.58) | (2.3,2.72,3.14;1.87,2.72,3.59) |
| R-A | (0.38,0.4044;0.36,0.4,0.49) | (1.89,2.04,2.17;1.72,2.04,2.29) | (1,1,1; 1,1,1) | (4.7,5.72,6.73;3.68,5.72,7.74) |
| W-T | (0.13,0.14,0.16;0.12,0.14,0.19) | (0.32,0.37,0.44;0.28,0.37,0.53) | (0.15,0.17,0.21;0.13,0.17,0.27) | (1,1,1; 1,1,1) |
| CR = 0.023 < 0.1 | ||||
Pair-wise comparison of sub-criteria for utility
| HLA matching | ABO | Age Difference | Survival Predicted | |
|---|---|---|---|---|
| HLA | (1,1,1; 1,1,1) | (1.34,1.43,1.52;1.24,1.43,1.6) | (3.23,3.65,4.05;2.79,3.65,4.43) | (0.96,1.17,1.45;0.79,1.17,1.95) |
| ABO | (0.66,0.7,0.75;0.62,0.7,0.81) | (1,1,1; 1,1,1) | (1.52,1.68,1.83;1.34,1.68,2) | (0.21,0.25,0.31;0.18,0.25,0.41) |
| A-D | (0.25,0.27,0.31;0.23,0.27,0.36) | (0.55,0.6,0.66;0.5,0.6,0.74) | (1,1,1;1,1,1) | (0.33,0.37,0.42;0.3,0.37,0.5) |
| S-P | (0.7,0.86,1.04;0.51,0.86,1.27) | (3.2,3.94,4.7;2.43,3.94,5.52) | (2.4,2.72,3.02;2.03,2.72,3.3) | (1,1,1;1,1,1) |
| CR = 0.06272 < 0.1 | ||||
Local and global weights of all criteria and sub-criteria using IFAHP method
| Criteria | Relative weights using IFAHP | Sub-criteria | Relative weights using IFAHP | Rank | Global weights using IFAHP | Rank |
|---|---|---|---|---|---|---|
| Equity | 0.33 | Medical urgency | 0.54 |
| 0.1782 | 1 |
| PRA | 0.14 | 3 | 0.0462 | 9 | ||
| Recipient age | 0.27 | 2 | ||||
| - < 11 years (0.54) | 0.048114 | 8 | ||||
| - 11–15 years (0.29) | 0.025839 | 10 | ||||
| - 15–18 years(0.16) | 0.014256 | 16 | ||||
| Waiting timea | 0.05 | 4 | 0.0165 | 14 | ||
| Utility | 0.67 | HLA matching | 0.35 | 2 | ||
| - 0 mismatches(0.56) | 0.13132 | 3 | ||||
| - 1 mismatch (0.21) | 0.049245 | 7 | ||||
| - 2 mismatches (0.11) | 0.025795 | 11 | ||||
| - 3 mismatches (0.06) | 0.01407 | 17 | ||||
| - 4 mismatches (0.04) | 0.00938 | 18 | ||||
| - 5 mismatches (0.02) | 0.00469 | 20 | ||||
| Blood type compatibility | 0.16 | 3 | ||||
| - Identical (0.83) | 0.088976 | 4 | ||||
| - Compatible (0.17) | 0.018224 | 12 | ||||
| Age difference | 0.11 | 4 | ||||
| - < 5 years (0.69) | 0.050853 | 6 | ||||
| - 5–15 years (0.24) | 0.017688 | 13 | ||||
| - > 15 years (0.07) | 0.005159 | 19 | ||||
| Predicted survival | 0.38 | 1 | ||||
| - < 1 years (0.06) | 0.015276 | 15 | ||||
| - 1–5 years (0.26) | 0.066196 | 5 | ||||
| - > 5 years (0.68) | 0.173128 | 2 |
aCalculated weight for waiting time is for one year
Highest and lowest points in several allocation algorithms
| Country (Algorithm) | Highest point | Lowest point | Source |
|---|---|---|---|
| Euro-transplant (ETKAS) | High Urgency, simultaneous liver-kidney transplant, a prior living donor (500 points) | Waiting time, 5 HLA mismatches, Recipient age 11–16 years (33.3 points) | [ |
| Australia | Zero HLA mismatches and peak PRA > 50% (60,000,000 points) | Waiting time (1200 points) | [ |
| New Zealand | DR HLA mismatches (2200 point in Rank 1, 300 points in Rank 2) | Waiting time (12 points in Rank 1, 36 points in Rank 2) | [ |
| Turkey (TONKS) | Zero HLA mismatches (7 points) | 3 HLA mismatches (0 points) | [ |
| Proposed model | Medical Urgency (global weight = 0.1782) | 5 HLA mismatches (global weight = 0.0046) |
US kidney allocation system (KAS) was not included since it is not based strictly on a points system, but rather is a classification-driven system with points playing a secondary role. In KAS, patients are first ordered by classification, and points are only used to further sort patients within classification. KAS awards very high priority for zero HLA mismatch, highly sensitized patients (CPRA 98–100%), prior living donors, and pediatric patients [54]
Comparing the results of the developed model and the current allocation model in Iran
| Measures | Recipient type | Developed model | Current model |
|---|---|---|---|
| Measures of utility | |||
| The number of recipients with an EPTS < 20% | Adult | 124 of 228 (54%) | 83 of 230 (36%) |
| Average EPTS score of recipients(%) | Adult | 24.61% | 41.37% |
| Average age difference between donors and recipients | All | 5.3 years | 8.1 years |
| The number of allocation with the identical blood type | All | 243 of 248 (98%) | 248 of 248 (100%) |
| Measures of equity | |||
| Average waiting time of all recipients | All | 1.25 years | 1.7 years |
| Average waiting time of urgency patients | Urgency | 1.1 years | 0.9 years |
| The number of recipients< 18 y out of patients< 18 y waiting | Pediatric | 20 of 22 | 18 of 22 |
Patients’ scores and the ranks in proposed model for all the 30 patients
| Patient Id | Patients’ factors | Utility score | Equity score | Total score | Patient Rank (proposed model) | |||
|---|---|---|---|---|---|---|---|---|
| M-U | ABO | WT | Age | |||||
| 1 | Yes | O | 23 | 74 | 0.293 | 0.255 | 0.548 | 3 |
| 2 | No | O | 5 | 8 | 0.338 | 0.079 | 0.417 | 8 |
| 3 | No | O | 7 | 38 | 0.135 | 0.055 | 0.190 | 23 |
| 4 | No | O | 30 | 7 | 0.368 | 0.134 | 0.502 | 4 |
| 5 | No | O | 44 | 34 | 0.135 | 0.105 | 0.240 | 21 |
| 6 | No | O | 20 | 44 | 0.135 | 0.073 | 0.208 | 22 |
| 7 | Yes | O | 46 | 35 | 0.293 | 0.285 | 0.578 | 1 |
| 8 | No | O | 25 | 48 | 0.368 | 0.127 | 0.495 | 5 |
| 9 | No | O | 28 | 24 | 0.293 | 0.083 | 0.376 | 11 |
| 10 | No | O | 2 | 35 | 0.338 | 0.075 | 0.413 | 9 |
| 11 | No | O | 17 | 32 | 0.368 | 0.069 | 0.437 | 7 |
| 12 | No | O | 13 | 58 | 0.368 | 0.111 | 0.479 | 6 |
| 13 | No | O | 10 | 9 | 0.293 | 0.059 | 0.352 | 12 |
| 14 | No | O | 8 | 36 | 0.293 | 0.057 | 0.350 | 13 |
| 15 | Yes | O | 5 | 15 | 0.293 | 0.257 | 0.550 | 2 |
| 16 | No | A | 1 | 34 | 0.223 | 0.095 | 0.318 | 14 |
| 17 | No | AB | 20 | 51 | 0.116 | 0.073 | 0.189 | 24 |
| 18 | No | A | 20 | 58 | 0.065 | 0.073 | 0.138 | 29 |
| 19 | No | B | 17 | 34 | 0.116 | 0.069 | 0.185 | 25 |
| 20 | No | B | 16 | 14 | 0.223 | 0.067 | 0.290 | 15 |
| 21 | No | AB | 13 | 6 | 0.223 | 0.063 | 0.286 | 16 |
| 22 | No | A | 13 | 38 | 0.223 | 0.063 | 0.286 | 17 |
| 23 | No | A | 11 | 46 | 0.116 | 0.061 | 0.177 | 26 |
| 24 | No | A | 11 | 34 | 0.065 | 0.061 | 0.126 | 30 |
| 25 | No | B | 11 | 56 | 0.223 | 0.061 | 0.284 | 18 |
| 26 | No | AB | 10 | 55 | 0.223 | 0.059 | 0.282 | 19 |
| 27 | No | B | 9 | 54 | 0.116 | 0.058 | 0.174 | 27 |
| 28 | No | A | 9 | 13 | 0.298 | 0.106 | 0.404 | 10 |
| 29 | No | A | 9 | 3 | 0.116 | 0.058 | 0.174 | 28 |
| 30 | No | AB | 8 | 39 | 0.223 | 0.057 | 0.280 | 20 |
Fig. 4Patients’ scores plot of utility versus equity